NR3C2 and primary aldosteronism: The preliminary study by Zhao et al. demonstrated rapid resorption of subretinal fluid in 2 subjects with unresolved CSC after oral treatment with eplerenone, MR antagonists used in the treatment of primary aldosteronism and hypertension [65].